A Phase 2 interventional study of Cenobamate in Epilepsies, Partial, sponsored by Ono Pharmaceutical Co. Ltd. Recruiting at 29 sites in Japan. Per ClinicalTrials.gov, last updated 2025-06-03.
Sponsored by Ono Pharmaceutical Co. Ltd · Phase 2, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
To evaluate the long-term safety and tolerability of cenobamate in Japanese epilepsy patients with partial seizures
243 studies on the registry are indexed under Epilepsies, Partial; 49 are open to participants now.
This study's planned enrollment of 100 is above the median of 90 across 187 interventional studies indexed under Epilepsies, Partial.
Browse Epilepsies, Partial studies →Ono Pharmaceutical Co. Ltd is the lead sponsor of 63 studies on the registry; 2 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 1 (20%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Drug: Cenobamate
Cenobamate will be orally administered once daily.
Incidences of Adverse Events (AEs) and Serious Adverse Events (SAEs)
The incidences of adverse events (AEs) and serious adverse events (SAEs) will be recorded.
Time frame: Through study completion, an average of 4 years
Urinalysis(pH)
Measurement of urine pH.
Time frame: Through study completion, an average of 4 years
Urinalysis(Specific Gravity)
Measurement of urine specific gravity (g/mL).
Time frame: Through study completion, an average of 4 years
Urinalysis(Protein)
Measurement of urine protein (mg/dL).
Time frame: Through study completion, an average of 4 years
Urinalysis(Glucose)
Measurement of urine glucose (mg/dL).
Time frame: Through study completion, an average of 4 years
Urinalysis(Ketone)
Measurement of urine ketone (mg/dL).
Time frame: Through study completion, an average of 4 years
Urinalysis(Bilirubin)
Measurement of urine bilirubin (mg/dL).
Time frame: Through study completion, an average of 4 years
Urinalysis(Blood)
Measurement of urine blood (presence/absence).
Time frame: Through study completion, an average of 4 years
Urinalysis(Nitrite)
Measurement of urine nitrite (presence/absence).
Time frame: Through study completion, an average of 4 years
Urinalysis(Urobilinogen)
Measurement of urine urobilinogen (mg/dL).
Time frame: Through study completion, an average of 4 years
Urinalysis( Microscopic Examination)
Microscopic examination of urine (if abnormal).
Time frame: Through study completion, an average of 4 years
Liver function tests(total protein)
Measurement of total protein(g/dL)
Time frame: Through study completion, an average of 4 years
Liver function tests(albumin)
Measurement of albumin(g/dL)
Time frame: Through study completion, an average of 4 years
Liver function tests(total bilirubin)
Measurement of total bilirubin(mg/dL)
Time frame: Through study completion, an average of 4 years
Liver function tests(aspartate transaminase)
Measurement of aspartate transaminase(U/L)
Time frame: Through study completion, an average of 4 years
Liver function tests(alanine aminotransferase)
Measurement of alanine aminotransferase(U/L)
Time frame: Through study completion, an average of 4 years
Liver function tests(alkaline phosphatase)
alkaline phosphatase(U/L)
Time frame: Through study completion, an average of 4 years
Liver function tests(gamma-glutamyl transferase)
Measurement of gamma-glutamyl transferase(U/L)
Time frame: Through study completion, an average of 4 years
Hematology(Hemoglobin)
Measurement of hemoglobin(g/dL)
Time frame: Through study completion, an average of 4 years
Hematology(hematocrit)
Measurement of hematocrit(%)
Time frame: Through study completion, an average of 4 years
Hematology(white blood cell count)
Measurement of white blood cell count(/μL)
Time frame: Through study completion, an average of 4 years
Hematology(red blood cell count)
Measurement of red blood cell count(/μL)
Time frame: Through study completion, an average of 4 years
Hematology(mean corpuscular volume)
Measurement of mean corpuscular volume(fL)
Time frame: Through study completion, an average of 4 years
Hematology(mean corpuscular hemoglobin)
Measurement of mean corpuscular hemoglobin(pg)
Time frame: Through study completion, an average of 4 years
Hematology(red blood cell distribution width)
Measurement of red blood cell distribution width(%)
Time frame: Through study completion, an average of 4 years
Hematology(platelet count)
Measurement of platelet count(/μL)
Time frame: Through study completion, an average of 4 years
Serum chemistry(blood urea nitrogen)
Measurement of blood urea nitrogen(mg/dL)
Time frame: Through study completion, an average of 4 years
Serum chemistry(calcium)
Measurement of calcium(mg/dL)
Time frame: Through study completion, an average of 4 years
Serum chemistry(chloride)
Measurement of chloride(mEq/L)
Time frame: Through study completion, an average of 4 years
Serum chemistry(creatinine)
Measurement of creatinine(mg/dL)
Time frame: Through study completion, an average of 4 years
Serum chemistry(total bilirubin)
Measurement of total bilirubin(mg/dL)
Time frame: Through study completion, an average of 4 years
Serum chemistry(direct bilirubin)
Measurement of direct bilirubin(mg/dL)
Time frame: Through study completion, an average of 4 years
Serum chemistry(alkaline phosphatase)
Measurement of alkaline phosphatas(U/L)
Time frame: Through study completion, an average of 4 years
Serum chemistry(alanine aminotransferase)
Measurement of alanine aminotransferase(U/L)
Time frame: Through study completion, an average of 4 years
Serum chemistry(gamma-glutamyl transferase)
Measurement of gamma-glutamyl transferase(U/L)
Time frame: Through study completion, an average of 4 years
Serum chemistry(total protein)
Measurement of total protein(g/dL)
Time frame: Through study completion, an average of 4 years
Serum chemistry(albumin)
Measurement of albumin(g/dL)
Time frame: Through study completion, an average of 4 years
Serum chemistry(globulin)
Measurement of globulin(g/dL)
Time frame: Through study completion, an average of 4 years
Serum chemistry(sodium)
Measurement of sodium(mEq/L)
Time frame: Through study completion, an average of 4 years
Serum chemistry(potassium)
Measurement of potassium(mEq/L)
Time frame: Through study completion, an average of 4 years
Serum chemistry(phosphorus)
Measurement of phosphorus(mq/dL)
Time frame: Through study completion, an average of 4 years
Serum chemistry(glucose)
Measurement of glucose(mq/dL)
Time frame: Through study completion, an average of 4 years
Heart rate
heart rate (beats per minute)
Time frame: Through study completion, an average of 4 years
Respiratory Rate
Respiratory Rate (breaths per minute),
Time frame: Through study completion, an average of 4 years
Blood Pressure
blood pressure, both of systolic and diastolic (mm Hg)
Time frame: Through study completion, an average of 4 years
Electrocardiogram (ECG) Findings
ECG findings, including heart rate (beats per minute), PR Interval (milliseconds), PQ Interval (milliseconds), RR Interval (milliseconds), QRS Interval (milliseconds), and QT Interval (milliseconds), will be recorded.
Time frame: Through study completion, an average of 4 years
Columbia-Suicide Severity Rating Scale (C-SSRS) Scores
Scores on the Columbia-Suicide Severity Rating Scale (C-SSRS) will be recorded. Questions regarding suicide are recorded as yes or no, and the percentage of subject with suicide risk (yes) is assessed.
Time frame: Through study completion, an average of 4 years
Percentage Change in all partial seizure frequency per 28-Day
It will confirm the frequency of partial seizures at 28-day intervals and calculate the percentage change until the study is completed.
Time frame: Through study completion, an average of 4 years
Plan to share: No
No publications or documents are linked to this record.
Started Nov 2022 (actual). Primary completion is estimated for Jan 2027, 50 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Cenobamate